ArticleInfection and drug resistance2019
Characterization Of
Article in Infection and drug resistance, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
21 citing papers in PubMed, 34 citations in OpenAlex.
- Clinical and genomic determinants associated with emergent ceftazidime-avibactam plus aztreonam non-susceptibility in ceftazidime-avibactam resistantAntimicrobial agents and chemotherapy · 2026Article
- Cross-species transmission ofFrontiers in cellular and infection microbiology · 2026Review
- Molecular characterization of ESBL- and carbapenemase-producing Enterobacteriaceae isolated from cats in Lebanon.BMC microbiology · 2025Article
- Molecular characterization of blaBMC infectious diseases · 2025Article
- Article
- Global emergence of a hypervirulent carbapenem-resistant Escherichia coli ST410 clone.Nature communications · 2024Article
- Coexistence of a novel NDM-1-encoding MDR plasmid and an IMP-4-encoding IncN-IncU hybrid plasmid in a clinical isolate ofFrontiers in microbiology · 2024Article
- Study of the Epidemiological and Mechanistic Differences Between Carbapenem-ResistantInfection and drug resistance · 2024Article
- Carbapenem Resistance in Animal-Environment-Food from Africa: A Systematic Review, Recommendations and Perspectives.Infection and drug resistance · 2024Review
- Antimicrobial resistance and molecular epidemiology of carbapenem-resistant Escherichia coli from urinary tract infections in Shandong, China.International microbiology : the official journal of the Spanish Society for Microbiology · 2023Review
- Complete-genome sequencing and comparative genomic characterization of blaBMC genomics · 2023Article
- Characterization of NDM-5-ProducingGenes · 2023Article
- First identification ofJournal of medical microbiology · 2022Article
- Global prevalence, characteristics, and future prospects of IncX3 plasmids: A review.Frontiers in microbiology · 2022Review
- Targeted Elimination ofInfection and drug resistance · 2022Article
- Genetic characterization of Carbapenem-Resistant Escherichia coli from China, 2015-2017.BMC microbiology · 2021Article
- Synergistic Antibacterial Effects of Meropenem in Combination with Aminoglycosides against Carbapenem-ResistantAntibiotics (Basel, Switzerland) · 2021Article
- Clinical and Microbiological Characteristics of a Community-Acquired Carbapenem-ResistantFrontiers in medicine · 2021Article
- Emergence of an NDM-5-ProducingInfection and drug resistance · 2020Article
- Emergence of NDM-5-ProducingFrontiers in microbiology · 2020Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purposeThe emergence and spread of carbapenem-resistant
methodsAll carbapenem-resistant strains were collected from July 2017 to July 2018 of the First Affiliated Hospital of Nanjing Medical University. The presence of carbapenemase-encoding genes was detected using PCR and gene sequencing. Genetic relatedness of the
resultsAmong the 28 carbapenem-resistant
conclusionThe clonal spread of
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.